65 institutions reported holding $73.4M of KALARIS THERAPEUTICS INC (KLRS) in SEC 13F filings for 2026-06-30. Largest institutional holders: SAMSARA BIOCAPITAL, LLC ($52.4M), RTW INVESTMENTS, LP ($5.3M), Alyeska Investment Group, L.P. ($2.3M), VANGUARD GROUP INC ($1.9M), Siren, L.L.C. ($1.8M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30